Thus, all identified CKD-DAMPs, alone or in combination, can promote foam cell formation in a TLR2/4-dependent manner and this effect likely results from the DAMPs’ ability to reduce cholesterol efflux. The gene discussed is TLR2; the disease is chronic kidney disease.